CBER (Center for Biologics Evaluation and Research)

The Center for Biologics Evaluation and Research (CBER) is a part of the U.S. Food and Drug Administration (FDA) that focuses on overseeing biologics—products derived from living organisms. This includes vaccines, blood products, and cell or gene therapies. CBER ensures these products are safe, effective, and manufactured to high standards by reviewing research and testing data before they can be used by the public. They also monitor the products once they are on the market to protect public health and ensure ongoing safety and efficacy.